Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.22B
+9.8% from 2023
Prescriptions
50K
$24,221.62 per claim
Patients
9,180
5,862 prescribers
Total spending, 2024
$1.22B
$132,511.98 per patient
Medicare prescription drug plans paid $1.22B for Cabometyx in 2024, for 50,215 prescriptions and refills to 9,180 patients (up 9.8% from 2023). The average cost per claim was $24,221.62.
California had the highest Medicare cost for Cabometyx in 2024: $135.3M for 5,545 claims, followed by Texas ($109.3M).
Sumanta K Pal, medical oncology in Duarte, CA, had the highest Medicare cost for Cabometyx in 2024: 130 claims costing $3.3M.
Cabometyx is made by Exelixis, Inc. (EXEL), listed in the Medicare spending data as Exelixis, Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sumanta K Pal Duarte, CA | Medical Oncology | 130 | 22 | $3.3M |
| Mehmet A Bilen Atlanta, GA | Hematology-Oncology | 129 | 20 | $2.9M |
| Joseph I Clark Maywood, IL |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 4,734 | 38,668 | 7,314 | $919.2M |
| 2023 | 5,251 | 42,989 | 8,191 | $1.11B |
| 2024 | 5,862 | 50,215 | 9,180 | $1.22B |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 141 |
| 23 |
| $2.8M |
| Zin W Myint Lexington, KY | Medical Oncology | 118 | 17 | $2.8M |
| Zita D Lim Houston, TX | Physician Assistant | 107 | 19 | $2.6M |
| Montaser Shaheen San Antonio, TX | Hematology | 99 | 20 | $2.6M |
| Adanma Anji Ayanambakkam Attanathi Oklahoma City, OK | Hematology-Oncology | 100 | 22 | $2.5M |
| Caitilin M Gnan Houston, TX | Nurse Practitioner | 109 | 13 | $2.5M |
| Ajjai S Alva Overland Park, KS | Medical Oncology | 103 | 16 | $2.4M |
| Martin H Voss New York, NY | Medical Oncology | 121 | 22 | $2.3M |
| Rahul A Parikh Westwood, KS | Hematology-Oncology | 100 | 18 | $2.3M |
| Tarenne A Carrington Philadelphia, PA | Nurse Practitioner | 99 | 17 | $2.1M |
| Patrick Curran III Boston, MA | Nurse Practitioner | 100 | 17 | $2.1M |
| Benjamin Gerendash Duarte, CA | Nurse Practitioner | 85 | 12 | $2.1M |
| Jessica N Snider Springfield, MO | Hematology-Oncology | 102 | Under 11 | $2.0M |
| Eric Jonasch Houston, TX | Medical Oncology | 81 | 15 | $2.0M |
| Amol N Rakkar Glendale, AZ | Hematology-Oncology | 80 | 12 | $2.0M |
| Gautam G Jha Minneapolis, MN | Hematology-Oncology | 79 | 14 | $1.9M |
| Melissa A Reimers Saint Louis, MO | Medical Oncology | 74 | 14 | $1.9M |
| Ajay Sehgal Corpus Christi, TX | Hematology-Oncology | 75 | 11 | $1.9M |
| Marcia S Brose Philadelphia, PA | Medical Oncology | 49 | Under 11 | $1.8M |
| Moshe C Ornstein Cleveland, OH | Hematology-Oncology | 96 | 12 | $1.8M |
| Mary K O'Keeffe Mineola, NY | Hematology-Oncology | 72 | Under 11 | $1.8M |
| Brian I Rini Nashville, TN | Hematology-Oncology | 86 | 12 | $1.8M |
| Raymel Hernandez Cutler Bay, FL | Nurse Practitioner | 58 | Under 11 | $1.8M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Exelixis, Inc. EXEL | 50,232 | $1.22B |